"Antimalarials" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585)
| Descriptor ID |
D000962
|
| MeSH Number(s) |
D27.505.954.122.250.100.085
|
| Concept/Terms |
Antimalarials- Antimalarials
- Antimalarial Agents
- Agents, Antimalarial
- Antimalarial Drugs
- Drugs, Antimalarial
- Anti-Malarials
- Anti Malarials
|
Below are MeSH descriptors whose meaning is more general than "Antimalarials".
Below are MeSH descriptors whose meaning is more specific than "Antimalarials".
This graph shows the total number of publications written about "Antimalarials" by people in this website by year, and whether "Antimalarials" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 1 | 1 |
| 2006 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 3 | 1 | 4 |
| 2010 | 2 | 1 | 3 |
| 2011 | 0 | 1 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 1 | 2 |
| 2018 | 0 | 1 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 2 | 2 | 4 |
| 2021 | 1 | 1 | 2 |
| 2022 | 2 | 0 | 2 |
| 2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antimalarials" by people in Profiles.
-
Nonclassical mechanisms to irreversibly suppress ?-hematin crystal growth. Commun Biol. 2023 07 27; 6(1):783.
-
Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana. Microbiol Spectr. 2023 06 15; 11(3):e0491622.
-
Hypnozoite depletion in successive Plasmodium vivax relapses. PLoS Negl Trop Dis. 2022 07; 16(7):e0010648.
-
Inhibiting protein synthesis to treat malaria. Science. 2022 06 03; 376(6597):1049-1050.
-
Targeting Host Glycolysis as a Strategy for Antimalarial Development. Front Cell Infect Microbiol. 2021; 11:730413.
-
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options. Am J Clin Dermatol. 2022 Jan; 23(1):37-50.
-
Updates on Hydroxychloroquine in Prevention and Treatment of COVID-19. Am J Med. 2022 01; 135(1):7-9.
-
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study. PLoS One. 2020; 15(8):e0237693.
-
Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic. JAMA Netw Open. 2020 07 01; 3(7):e2015100.
-
Fever Management in Sickle Cell Disease in Low- and Middle-Income Countries: A Survey of SCD Management Programs. Am J Trop Med Hyg. 2020 04; 102(4):902-904.